Factors Associated with CMV Disease in Pediatric Hematopoietic Stem Cell Transplantation

Robert Grant Rowe, Christine Duncan, Steven Margossian, Michelle Lee, Leslie E. Lehmann
2015 Biology of Blood and Marrow Transplantation  
statistically significant difference (p 0.02) compared with those subjected to HT as a first choice. OS of 70% was reported at 40 months. OS and DFS for children with leukemia was 75% and 40%, respectively. For children with immunodeficiencies it was 65% and 15%, respectively, with a 40-month follow-up
doi:10.1016/j.bbmt.2014.11.365 fatcat:mauzxj3lingnfbgbbbzixqotuu